{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:31:43Z","timestamp":1790839903905,"version":"4.1.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Candida krusei is diploid, dimorphic, opportunistic yeast belonging to the methylotrophic clade, known for causing infections primarily in immunocompromised individuals. It is globally distributed with variable prevalence across regions and patient populations. C krusei has been associated with several nosocomial outbreaks, particularly in neonatal intensive care units. A key concern is its intrinsic resistance to fluconazole, often resulting in high mortality. The mechanisms of azole resistance are complex and include low affinity of the Erg11p enzyme, overexpression of efflux pumps, and mutations in the ABC11 gene. Additionally, echinocandin resistance has emerged due to mutations in the hotspot regions of the FKS1 gene. Its biofilm-forming ability further enhances its survival against antifungal agents and immune responses. This study highlights C krusei as a clinically significant and emerging fungal pathogen, emphasizing the need for enhanced surveillance, molecular monitoring, and continued research to mitigate its growing threat in healthcare settings.<\/jats:p>","DOI":"10.1093\/ofid\/ofaf742","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:06:09Z","timestamp":1765544769000},"source":"Crossref","is-referenced-by-count":10,"title":["Genomic Insights of\n                    <i>Candida krusei<\/i>\n                    , an Emerging Fungal Pathogen With Intrinsic Antifungal Resistance"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8417-5784","authenticated-orcid":false,"given":"Kusum","family":"Jain","sequence":"first","affiliation":[{"name":"Fungal Biology Laboratory, Department of Zoology, Ramjas College, University of Delhi , Delhi ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushbu","family":"Wadhwa","sequence":"additional","affiliation":[{"name":"Fungal Biology Laboratory, Department of Zoology, Ramjas College, University of Delhi , Delhi ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8025-1913","authenticated-orcid":false,"given":"Meenakshi","family":"Malik","sequence":"additional","affiliation":[{"name":"Fungal Biology Laboratory, Department of Zoology, Ramjas College, University of Delhi , Delhi ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2989-121X","authenticated-orcid":false,"given":"Shafiul","family":"Haque","sequence":"additional","affiliation":[{"name":"Department of Nursing, College of Nursing and Health Sciences, Jazan University , Jazan ,","place":["Saudi Arabia"]},{"name":"School of Medicine, Universidad Espiritu Santo , Samborondon ,","place":["Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-0054","authenticated-orcid":false,"given":"Miguel A","family":"Prieto","sequence":"additional","affiliation":[{"name":"Instituto de Agroecoloxi\u0301a e Alimentacio\u0301n (IAA), Universidade de Vigo, Nutrition and Food Group (NuFoG), Campus Auga, Ourense ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7136-7972","authenticated-orcid":false,"given":"Hardeep","family":"Kaur","sequence":"additional","affiliation":[{"name":"Fungal Biology Laboratory, Department of Zoology, Ramjas College, University of Delhi , Delhi ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"2026011311165753200_ofaf742-B1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-024-00503-3","article-title":"Invasive candidiasis","volume":"10","author":"Lass-Florl","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"2026011311165753200_ofaf742-B2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1186\/s12879-025-11021-2","article-title":"Epidemiological characteristics, antifungal susceptibility, and mortality factors of candidemia in adults at a tertiary teaching hospital in Zunyi, China (2016\u20132023)","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Infect Dis"},{"key":"2026011311165753200_ofaf742-B3","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997\u20132016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2026011311165753200_ofaf742-B4","doi-asserted-by":"crossref","first-page":"e1007138","DOI":"10.1371\/journal.ppat.1007138","article-title":"Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: one species, four names","volume":"14","author":"Douglass","year":"2018","journal-title":"PLoS Pathog"},{"key":"2026011311165753200_ofaf742-B5","doi-asserted-by":"crossref","first-page":"e101510","DOI":"10.1371\/journal.pone.0101510","article-title":"Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004\u20132008","volume":"9","author":"Pfaller","year":"2014","journal-title":"PLoS One"},{"key":"2026011311165753200_ofaf742-B6","first-page":"276","article-title":"Upregulation of the ERG11 gene in Candida krusei by azoles","volume":"18","author":"Tavakoli","year":"2010","journal-title":"Daru"},{"key":"2026011311165753200_ofaf742-B7","doi-asserted-by":"crossref","first-page":"e0170924","DOI":"10.1128\/aac.01709-24","article-title":"Genomic analyses reveal high diversity and rapid evolution of Pichia kudriavzevii within a neonatal intensive care unit in Delhi, India","volume":"69","author":"Jain","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B8","doi-asserted-by":"crossref","first-page":"myad132","DOI":"10.1093\/mmy\/myad132","article-title":"Pichia kudriavzevii (Candida krusei): a systematic review to inform the World Health Organisation priority list of fungal pathogens","volume":"62","author":"Nguyen","year":"2024","journal-title":"Med Mycol"},{"key":"2026011311165753200_ofaf742-B9","doi-asserted-by":"crossref","first-page":"e0203221","DOI":"10.1128\/JCM.02032-21","article-title":"Development of a multiplex PCR short tandem repeat typing scheme for Candida krusei","volume":"60","author":"van Haren","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2026011311165753200_ofaf742-B10","first-page":"257","article-title":"Prolonged outbreak of Candida krusei candidemia in paediatric ward of tertiary care hospital","volume":"185","author":"Kaur","year":"2020","journal-title":"Mycopathologia"},{"key":"2026011311165753200_ofaf742-B11","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s41467-018-04374-7","article-title":"Evolutionary instability of CUG-Leu in the genetic code of budding yeasts","volume":"9","author":"Krassowski","year":"2018","journal-title":"Nat Commun"},{"key":"2026011311165753200_ofaf742-B12","doi-asserted-by":"crossref","first-page":"2411543","DOI":"10.1080\/21505594.2024.2411543","article-title":"Biology and genetic diversity of Candida krusei isolates from fermented vegetables and clinical samples in China","volume":"15","author":"Zheng","year":"2024","journal-title":"Virulence"},{"key":"2026011311165753200_ofaf742-B13","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1534\/g3.117.043547","article-title":"Whole genome sequence of the heterozygous clinical isolate Candida krusei 81-B-5","volume":"7","author":"Cuomo","year":"2017","journal-title":"G3 (Bethesda)"},{"key":"2026011311165753200_ofaf742-B14","doi-asserted-by":"crossref","first-page":"a019778","DOI":"10.1101\/cshperspect.a019778","article-title":"The Candida pathogenic species complex","volume":"4","author":"Turner","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026011311165753200_ofaf742-B15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: mechanisms of action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol"},{"key":"2026011311165753200_ofaf742-B16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1139\/w2012-077","article-title":"Candida krusei: biotechnological potentials and concerns about its safety","volume":"58","author":"Yadav","year":"2012","journal-title":"Can J Microbiol"},{"key":"2026011311165753200_ofaf742-B17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1099\/00222615-41-5-295","article-title":"Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen","volume":"41","author":"Samaranayake","year":"1994","journal-title":"J Med Microbiol"},{"key":"2026011311165753200_ofaf742-B18","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2147\/IDR.S247944","article-title":"Current aspects in the biology, pathogeny, and treatment of Candida krusei, a neglected fungal pathogen","volume":"13","author":"Gomez-Gaviria","year":"2020","journal-title":"Infect Drug Resist"},{"key":"2026011311165753200_ofaf742-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-0711-5-1","article-title":"Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida","volume":"5","author":"Hospenthal","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2026011311165753200_ofaf742-B20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0255-0857(21)02775-4","article-title":"Onycholysis caused by Candida krusei","volume":"22","author":"Rao","year":"2004","journal-title":"Indian J Med Microbiol"},{"key":"2026011311165753200_ofaf742-B21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12866-017-0972-z","article-title":"Candida krusei form mycelia along agar surfaces towards each other and other Candida species","volume":"17","author":"Fleischmann","year":"2017","journal-title":"BMC Microbiol"},{"key":"2026011311165753200_ofaf742-B22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1567-1364.2008.00384.x","article-title":"Candida krusei produces ethanol without production of succinic acid; a potential advantage for ethanol recovery by pervaporation membrane separation","volume":"8","author":"Nakayama","year":"2008","journal-title":"FEMS Yeast Res"},{"key":"2026011311165753200_ofaf742-B23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JCM.01915-07","article-title":"Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"2026011311165753200_ofaf742-B24","doi-asserted-by":"crossref","first-page":"e0245322","DOI":"10.1128\/spectrum.02453-22","article-title":"Epidemiology and antifungal susceptibility of Candida species isolated from 10 tertiary care hospitals in Iran","volume":"10","author":"Badiee","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2026011311165753200_ofaf742-B25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jinf.2023.08.001","article-title":"European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study","volume":"87","author":"Arendrup","year":"2023","journal-title":"J Infect"},{"key":"2026011311165753200_ofaf742-B26","first-page":"184","article-title":"A seven-year surveillance of Candida bloodstream infection at a university hospital in KSA","volume":"16","author":"Al-Musawi","year":"2021","journal-title":"J Taibah Univ Med Sci"},{"key":"2026011311165753200_ofaf742-B27","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s15010-025-02513-z","article-title":"Epidemiology and outcomes of Candida spp. bloodstream infections in cancer patients: a comparative retrospective study from a German tertiary cancer center","volume":"53","author":"Wolf","year":"2025","journal-title":"Infection"},{"key":"2026011311165753200_ofaf742-B28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/jof9040400","article-title":"Fungemia in hospitalized adult patients with hematological malignancies: epidemiology and risk factors","volume":"9","author":"Vargas-Espindola","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"2026011311165753200_ofaf742-B29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.31557\/APJCP.2025.26.3.839","article-title":"Incidence and risk factors for invasive fungal infection in patients with hematological malignancies at a tertiary hospital in Malaysia","volume":"26","author":"Cheong","year":"2025","journal-title":"Asian Pac J Cancer Prev"},{"key":"2026011311165753200_ofaf742-B30","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3201\/eid2407.171087","article-title":"Large outbreaks of fungal and bacterial bloodstream infections in a neonatal unit, South Africa, 2012\u20132016","volume":"24","author":"van Schalkwyk","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2026011311165753200_ofaf742-B31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/antibiotics14070666","article-title":"Congenital Candida krusei sepsis in an extremely preterm baby: case report and literature review","volume":"14","author":"Cossovel","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"2026011311165753200_ofaf742-B32","doi-asserted-by":"crossref","first-page":"e0185621","DOI":"10.1128\/AAC.01856-21","article-title":"Prevalence of antifungal resistance, genetic basis of acquired azole and echinocandin resistance, and genotyping of Candida krusei recovered from an international collection","volume":"66","author":"Khalifa","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/mmy\/myaa031","article-title":"Update on Candida krusei, a potential multidrug-resistant pathogen","volume":"59","author":"Jamiu","year":"2021","journal-title":"Med Mycol"},{"key":"2026011311165753200_ofaf742-B34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/antibiotics9060312","article-title":"Candidiasis and mechanisms of antifungal resistance","volume":"9","author":"Bhattacharya","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"2026011311165753200_ofaf742-B35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s44259-023-00007-2","article-title":"Molecular mechanisms governing antifungal drug resistance","volume":"1","author":"Lee","year":"2023","journal-title":"NPJ Antimicrob Resist"},{"key":"2026011311165753200_ofaf742-B36","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.3390\/cells12222655","article-title":"Molecular mechanisms associated with antifungal resistance in pathogenic Candida species","volume":"12","author":"Czajka","year":"2023","journal-title":"Cells"},{"key":"2026011311165753200_ofaf742-B37","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1128\/AAC.01005-15","article-title":"Rapid development of Candida krusei echinocandin resistance during caspofungin therapy","volume":"59","author":"Forastiero","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B38","doi-asserted-by":"crossref","first-page":"e0136185","DOI":"10.1371\/journal.pone.0136185","article-title":"Overexpression of both ERG11 and ABC2 genes might be responsible for itraconazole resistance in clinical isolates of Candida krusei","volume":"10","author":"He","year":"2015","journal-title":"PLoS One"},{"key":"2026011311165753200_ofaf742-B39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/AAC.01095-08","article-title":"Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei","volume":"53","author":"Lamping","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B40","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/AAC.02603-14","article-title":"In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei","volume":"58","author":"Ricardo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1590\/0074-02760150400","article-title":"Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species","volume":"111","author":"Silva","year":"2016","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2026011311165753200_ofaf742-B42","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1128\/AAC.40.11.2443","article-title":"Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance","volume":"40","author":"Venkateswarlu","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B43","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1534\/genetics.116.194811","article-title":"Role of ectopic gene conversion in the evolution of a Candida krusei pleiotropic drug resistance transporter family","volume":"205","author":"Lamping","year":"2017","journal-title":"Genetics"},{"key":"2026011311165753200_ofaf742-B44","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1128\/AAC.02367-14","article-title":"Echinocandin failure case due to a previously unreported FKS1 mutation in Candida krusei","volume":"58","author":"Jensen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B45","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/AAC.49.8.3264-3273.2005","article-title":"Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates","volume":"49","author":"Park","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B46","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026011311165753200_ofaf742-B47","doi-asserted-by":"crossref","first-page":"1148681","DOI":"10.3389\/fimmu.2023.1148681","article-title":"Post-translational modifications confer amphotericin B resistance in Candida krusei isolated from a neutropenic patient","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"2026011311165753200_ofaf742-B48","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3390\/microorganisms11081934","article-title":"Microbial biofilms: applications, clinical consequences, and alternative therapies","volume":"11","author":"Ali","year":"2023","journal-title":"Microorganisms"},{"key":"2026011311165753200_ofaf742-B49","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/jof9100955","article-title":"Biofilm formation in medically important Candida species","volume":"9","author":"Malinovska","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"2026011311165753200_ofaf742-B50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/myc.13049","article-title":"Candida biofilm production is associated with higher mortality in patients with candidaemia","volume":"63","author":"Vitalis","year":"2020","journal-title":"Mycoses"},{"key":"2026011311165753200_ofaf742-B51","doi-asserted-by":"crossref","first-page":"e0263522","DOI":"10.1371\/journal.pone.0263522","article-title":"Prevalence of biofilms in Candida spp. bloodstream infections: a meta-analysis","volume":"17","author":"Atiencia-Carrera","year":"2022","journal-title":"PLoS One"},{"key":"2026011311165753200_ofaf742-B52","doi-asserted-by":"crossref","first-page":"953168","DOI":"10.3389\/fcimb.2022.953168","article-title":"Evaluation of the biofilm life cycle between Candida albicans and Candida tropicalis","volume":"12","author":"Atiencia-Carrera","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2026011311165753200_ofaf742-B53","doi-asserted-by":"crossref","first-page":"794529","DOI":"10.3389\/fcimb.2021.794529","article-title":"Using genomics to shape the definition of the agglutinin-like sequence (ALS) family in the Saccharomycetales","volume":"11","author":"Oh","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2026011311165753200_ofaf742-B54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/CMR.13.1.122","article-title":"Potential role of phospholipases in virulence and fungal pathogenesis","volume":"13","author":"Ghannoum","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"2026011311165753200_ofaf742-B55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4103\/JLP.JLP_81_18","article-title":"Extracellular hydrolytic enzyme activities of the different Candida spp. isolated from the blood of the intensive care unit-admitted patients","volume":"10","author":"Pandey","year":"2018","journal-title":"J Lab Physicians"},{"key":"2026011311165753200_ofaf742-B56","first-page":"e44213","article-title":"Antifungal resistance profile, biofilm formation, and virulence factor production in Candida krusei isolates from HIV-infected patients in Cameroon","volume":"15","author":"Kountchou","year":"2023","journal-title":"Cureus"},{"key":"2026011311165753200_ofaf742-B57","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front Microbiol"},{"key":"2026011311165753200_ofaf742-B58","doi-asserted-by":"crossref","first-page":"e0227876","DOI":"10.1371\/journal.pone.0227876","article-title":"Promising antifungal activity of new oxadiazole against Candida krusei","volume":"15","author":"Faria","year":"2020","journal-title":"PLoS One"},{"key":"2026011311165753200_ofaf742-B59","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.48.2.388-391.2004","article-title":"In vitro and in vivo activities of the novel azole antifungal agent r126638","volume":"48","author":"Odds","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/biomedicines12020389","article-title":"A preliminary evaluation on the antifungal efficacy of vt-1161 against persister Candida albicans cells in vulvovaginal candidiasis","volume":"12","author":"Sinoca","year":"2024","journal-title":"Biomedicines"},{"key":"2026011311165753200_ofaf742-B61","doi-asserted-by":"crossref","first-page":"e01817-16","DOI":"10.1128\/AAC.01817-16","article-title":"Fungal CYP51 inhibitors VT-1161 and VT-1129 exhibit strong in vitro activity against Candida glabrata and C. krusei isolates clinically resistant to azole and echinocandin antifungal compounds","volume":"61","author":"Schell","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B62","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"2026011311165753200_ofaf742-B63","doi-asserted-by":"crossref","first-page":"e0244921","DOI":"10.1128\/jcm.02449-21","article-title":"Evaluation of rezafungin provisional CLSI clinical breakpoints and epidemiological cutoff values tested against a worldwide collection of contemporaneous invasive fungal isolates (2019 to 2020)","volume":"60","author":"Carvalhaes","year":"2022","journal-title":"J Clin Microbiol"},{"key":"2026011311165753200_ofaf742-B64","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.44.9.2356-2360.2000","article-title":"Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis","volume":"44","author":"Santangelo","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B65","doi-asserted-by":"crossref","first-page":"ofae346","DOI":"10.1093\/ofid\/ofae346","article-title":"Oral lipid nanocrystal amphotericin B (MAT2203) for the treatment of invasive fungal infections","volume":"11","author":"Dalton","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026011311165753200_ofaf742-B66","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3389\/fmicb.2020.00854","article-title":"Antifungal activity and mode of action of miltefosine against clinical isolates of Candida krusei","volume":"11","author":"Wu","year":"2020","journal-title":"Front Microbiol"},{"key":"2026011311165753200_ofaf742-B67","doi-asserted-by":"crossref","first-page":"368","DOI":"10.15386\/mpr-1209","article-title":"Antifungal effect of atorvastatin against Candida species in comparison to fluconazole and nystatin","volume":"92","author":"Esfahani","year":"2019","journal-title":"Med Pharm Rep"},{"key":"2026011311165753200_ofaf742-B68","doi-asserted-by":"crossref","first-page":"e00429-20","DOI":"10.1128\/AAC.00429-20","article-title":"Manogepix (APX001A) displays potent in vitro activity against human pathogenic yeast, but with an unexpected correlation to fluconazole MICs","volume":"64","author":"Arendrup","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B69","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/jof7050378","article-title":"In vitro activity of novel antifungal olorofim against filamentous fungi and comparison to eight other antifungal agents","volume":"7","author":"Georgacopoulos","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2026011311165753200_ofaf742-B70","doi-asserted-by":"crossref","first-page":"915.e5","DOI":"10.1016\/j.cmi.2021.02.006","article-title":"In vitro activity of ibrexafungerp and comparators against Candida albicans genotypes from vaginal samples and blood cultures","volume":"27","author":"Mesquida","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2026011311165753200_ofaf742-B71","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1093\/ofid\/ofx163.1218","article-title":"Fungal cytological profiling of Candida albicans exposed to diverse antifungal agents including the novel Gwt1 inhibitor APX001A","volume":"4","author":"Sharp","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2026011311165753200_ofaf742-B72","doi-asserted-by":"crossref","first-page":"e01527-20","DOI":"10.1128\/AAC.01527-20","article-title":"Olorofim susceptibility testing of 1,423 Danish mold isolates obtained in 2018\u20132019 confirms uniform and broad-spectrum activity","volume":"65","author":"Astvad","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B73","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1093\/jac\/dky329","article-title":"Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei","volume":"73","author":"Lackner","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2026011311165753200_ofaf742-B74","doi-asserted-by":"crossref","first-page":"e01692-19","DOI":"10.1128\/AAC.01692-19","article-title":"In vitro activity of Ibrexafungerp, a novel glucan synthase inhibitor against Candida glabrata isolates with FKS mutations","volume":"63","author":"Nunnally","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011311165753200_ofaf742-B75","doi-asserted-by":"crossref","first-page":"e02198-16","DOI":"10.1128\/AAC.02198-16","article-title":"Pharmacokinetics of miltefosine in children and adults with cutaneous leishmaniasis","volume":"61","author":"Castro","year":"2017","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf742\/65944425\/ofaf742.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/1\/ofaf742\/65944425\/ofaf742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/1\/ofaf742\/65944425\/ofaf742.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:17:11Z","timestamp":1768321031000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf742\/8382672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf742","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,17]]},"article-number":"ofaf742"}}